跳至主要内容
临床试验/ACTRN12623000280606
ACTRN12623000280606已完成1 期

Oral safety and tolerability of Eucalypt and Corymbia sap resins in healthy adults – A randomised controlled study

Integria Healthcare (Australia) Pty Ltd.0 个研究点目标入组 42 人开始时间: 2023年3月15日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Healthy male and female adults (18-65 years)
  • - For females of child-bearing potential – must be currently using (for at least 4 weeks) hormonal contraception for duration of trial and 4-weeks post-trial
  • - Any prescription medication use by participants must be stable for four weeks or more prior to trial entry

排除标准

  • - Pregnant, planning pregnancy or breastfeeding
  • - Taking warfarin or any other anti-coagulant medication
  • - Diagnosed with cancer (if active within last 5 years and excepting skin cancer)
  • - Currently unwell with acute infection or fever or having Covid-19 within the last 4 weeks
  • - Clinically assessed abnormal laboratory values (biochemical parameters) at baseline testing.
  • - In poor general health as assessed by Study Investigators

研究者

相似试验